Send me a link:

*Text messaging rates may apply.

 Dow Down0.02% Nasdaq Down0.04%

Protalix BioTherapeutics, Inc. (PLX)

-NYSE MKT
3.60 Up 0.23(6.82%) Jul 24, 4:02PM EDT
Income StatementGet Income Statement for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingMar 31, 2014Dec 31, 2013Sep 30, 2013Jun 30, 2013
Total Revenue 7,383   1,122   3,359   3,064  
Cost of Revenue4,073  1,552  1,587  1,318  
Gross Profit 3,310   (430) 1,772   1,746  
Operating Expenses
Research Development6,067  7,398  5,637  6,458  
Selling General and Administrative3,711  2,320  1,780  2,182  
Non Recurring -   -   -   -  
Others -   -   -   -  
Total Operating Expenses -   -   -   -  
Operating Income or Loss (6,468) (10,148) (5,645) (6,894)
Income from Continuing Operations
Total Other Income/Expenses Net38  (737)(102)43  
Earnings Before Interest And Taxes(6,430)(10,885)(5,747)(6,851)
Interest Expense915   -   -  (14)
Income Before Tax(7,345)(10,885)(5,747)(6,837)
Income Tax Expense -   -   -   -  
Minority Interest -   -   -   -  
Net Income From Continuing Ops(7,345)(10,885)(5,747)(6,837)
Non-recurring Events
Discontinued Operations -   -   -   -  
Extraordinary Items -   -   -   -  
Effect Of Accounting Changes -   -   -   -  
Other Items -   -   -   -  
Net Income (7,345) (10,885) (5,747) (6,837)
Preferred Stock And Other Adjustments -   -   -   -  
Net Income Applicable To Common Shares (7,345) (10,885) (5,747) (6,837)

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.